New York marketing agency Uber Inc agreed to dismiss its trademark infringement claims in Manhattan federal court against rideshare company Uber Technologies and its advertising partner Adomni over plans to display ads on its drivers' cars.
Uber Inc sued Uber Technologies and Adomni last year as the latter group's plan would supposedly create consumer confusion with the marketing agency, which has worked with such brands as BMW and Macy's.
Uber Inc, which has been using the "Uber" name since 1999, said it has dealt with "constant business interruptions" from transactions meant for the rideshare company.
The interruptions include customer complaints, product shipments, legal correspondence, and other communications
Uber Inc. has also rejected Uber Technologies' offer of $120,000 in exchange for changing its name.
Meanwhile, Adomni provides ad services for Uber Technologies as "Uber OOH."
US District Judge Kevin Castel found that Uber Inc made plausible claims that Uber Technologies infringed and diluted its trademarks.
Consequently, Castel rejected Uber Technologies' motion to dismiss the complaint in February.


USDA $12 Billion Farm Aid Program Draws Mixed Reactions from Row Crop Farmers
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Japanese Business Leaders Urge Government Action as Weak Yen Strains Economy
South Korea Factory Output Misses Forecasts in November Amid Ongoing Economic Uncertainty
Bolsonaro Undergoes Phrenic Nerve Block Procedure After Surgery-Related Complications
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Democratic Attorneys General Sue Trump Administration Over Proposed Limits on Gender-Affirming Care for Youth
South Korea Factory Activity Returns to Growth in December on Export Rebound
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Italy Supreme Court Upholds Salvini Acquittal in Migrant Kidnapping Case
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Oil Prices Stabilize at Start of 2026 as OPEC+ Policy and Geopolitical Risks Shape Market Outlook
U.S. Government Agrees to Review Frozen NIH Diversity Research Grants After Legal Challenge
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Bolsonaro Endorses Son Flavio for Brazil’s 2026 Presidential Election From Hospital
Forex Markets Hold Steady as Traders Await Fed Minutes Amid Thin Year-End Volumes 



